Scientists zero in on the role of volcanoes in the demise of dinosaurs
29 March 2021Researchers have uncovered evidence suggesting that volcanic carbon emissions were not a major driver in Earth’s most recent extinction event.
Autism rates have increased and show differences in ethnic minorities and links to social disadvantage
29 March 2021Around one in 57 (1.76%) children in the UK is on the autistic spectrum, significantly higher than previously reported, according to a study of more...
Growing Underground
29 March 2021In the heart of London there is a farm like no other. It's subterranean, sustainable and energy smart. It also has a digital twin looking...
Global evidence for how EdTech can support pupils with disabilities is ‘thinly spread’, report finds
26 March 2021An 'astonishing' deficit of data about how the global boom in educational technology could help pupils with disabilities in low and middle-income countries has been highlighted...
New genetic clues point to new treatments for ‘silent’ stroke
25 March 2021Scientists have identified new genetic clues in people who have had small and often apparently ‘silent’ strokes that are difficult to treat and a major...
Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital
25 March 2021A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.
The Kennel Club Genetics Centre to re-open as part of the University of Cambridge
23 March 2021Following the announcement in July 2020 of the closure of the Animal Health Trust, The Kennel Club Canine Genetics Centre will officially re-open and be located...
New result from LHCb experiment challenges leading theory in physics
23 March 2021UK particle physicists have today announced ‘intriguing’ results that potentially cannot be explained by the current laws of nature.
Hunting for COVID-19 variants
22 March 2021Professor Sharon Peacock explains the story behind the UK's world-leading SARS-CoV-2 genomics capability.
Cambridge leads trial to see if tapeworm drug can boost protection from COVID-19 among vulnerable
22 March 2021UK researchers are launching a clinical trial to investigate if the drug niclosamide, usually used to treat tapeworms, can prevent COVID-19 infection in vulnerable, high...